NASDAQ:MYGN Shareholder Notice: Lawsuit Alleges Securities Laws Violations by Myriad Genetics, Inc
An investor, who purchased shares of Myriad Genetics, Inc. (NASDAQ: MYGN), filed a lawsuit over alleged violations of Federal Securities Laws by Myriad Genetics, Inc. in connection with certain allegedly false and misleading statements.
View full press release